- Home
- SYPR vs RNXT Comparison
SYPR vs RNXT Comparison
Compare SYPR & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- RNXT
- Stock Information
- Founded
- SYPR 1997
- RNXT 2012
- Country
- SYPR United States
- RNXT United States
- Employees
- SYPR N/A
- RNXT N/A
- Industry
- SYPR Industrial Machinery/Components
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- SYPR Industrials
- RNXT Health Care
- Exchange
- SYPR Nasdaq
- RNXT Nasdaq
- Market Cap
- SYPR 36.8M
- RNXT 44.6M
- IPO Year
- SYPR 1994
- RNXT 2021
- Fundamental
- Price
- SYPR $1.97
- RNXT $1.40
- Analyst Decision
- SYPR
- RNXT Strong Buy
- Analyst Count
- SYPR 0
- RNXT 2
- Target Price
- SYPR N/A
- RNXT $7.00
- AVG Volume (30 Days)
- SYPR 29.2K
- RNXT 210.6K
- Earning Date
- SYPR 05-14-2025
- RNXT 05-15-2025
- Dividend Yield
- SYPR N/A
- RNXT N/A
- EPS Growth
- SYPR N/A
- RNXT N/A
- EPS
- SYPR N/A
- RNXT N/A
- Revenue
- SYPR $134,135,000.00
- RNXT $240,000.00
- Revenue This Year
- SYPR N/A
- RNXT $3,927.91
- Revenue Next Year
- SYPR N/A
- RNXT $219.75
- P/E Ratio
- SYPR N/A
- RNXT N/A
- Revenue Growth
- SYPR N/A
- RNXT N/A
- 52 Week Low
- SYPR $1.30
- RNXT $0.75
- 52 Week High
- SYPR $3.72
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- SYPR 63.95
- RNXT 78.13
- Support Level
- SYPR $1.75
- RNXT $1.17
- Resistance Level
- SYPR $2.07
- RNXT $1.30
- Average True Range (ATR)
- SYPR 0.12
- RNXT 0.08
- MACD
- SYPR 0.04
- RNXT 0.02
- Stochastic Oscillator
- SYPR 81.48
- RNXT 100.00
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.